REVIVA PHARMACEUTICALS HOLDI (RVPH) Stock Balance Sheet
NASDAQ:RVPH - Nasdaq - US76152G1004 - Common Stock
| MRQ (2024-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-2-29) | 2019 (2019-2-28) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.56M | 18.52M | 29.69M | 70.00K | 310.00K | |||
| Other Current Assets | 1.25M | 400.00K | 1.72M | 70.00K | 90.00K | |||
| Total Current Assets | 6.81M | 18.92M | 31.40M | 140.00K | 400.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | 0.00 | N/A | |||
| Investments And Advances | N/A | N/A | N/A | 60.88M | 65.24M | |||
| Other Non-Current Assets | 819.72K | N/A | N/A | 1.82K | N/A | |||
| Total Non-Current Assets | 819.72K | 0.00 | 0.00 | 60.88M | 65.25M | |||
| TOTAL ASSETS | 7.63M | 18.92M | 31.40M | 61.02M | 65.65M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 83.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.67M | 2.52M | 1.84M | 320.00K | N/A | |||
| Accounts Payable | 8.78M | 3.52M | 510.00K | 300.00K | 20.00K | |||
| Total Current Liabilities | 17.53M | 6.04M | 2.34M | 300.00K | 20.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 750.00K | 0.00 | |||
| Other Non-Current Liabilities | 77.88K | 570.00K | 370.00K | 2.21M | 2.21M | |||
| Total Non-Current Liabilities | 77.88K | 570.00K | 380.00K | 2.96M | 2.22M | |||
| TOTAL LIABILITIES | 17.61M | 6.61M | 2.72M | 3.26M | 2.24M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -158.01M | -91.17M | -66.83M | 1.19M | 570.00K | |||
| Additional Paid In Capital | 148.03M | 103.49M | 95.52M | 63.77M | N/A | |||
| Common Shares | 3.34K | 0.00 | 0.00 | 56.57M | 62.84M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | -58.31M | N/A | |||
| Shares Outstanding | 33.44M | 20.45M | 14.43M | 7.67M | 8.27M | |||
| Tangible Book Value per Share | -0.30 | 0.60 | 1.99 | 7.53 | 7.67 | |||
| Total Shareholders' Equity | -9.98M | 12.32M | 28.69M | 57.76M | 63.41M | |||
| TOTAL LIABILITIES AND EQUITY | 7.63M | 18.92M | 31.40M | 61.02M | 65.65M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.01 | N/A | |||
| Current Ratio | 0.39 | 3.13 | 13.42 | 0.47 | 20.00 | |||
| Return On Assets (ROA) | -437.54% | -128.65% | -27.13% | 1.02% | 0.87% | |||
| Return On Equity (ROE) | N/A | -197.56% | -29.70% | 1.07% | 0.90% | |||
All data in USD , ROIC based on taxRate of 0.25